Cyclopharm (ASX:CYC) Price-to-Operating-Cash-Flow : (As of Jun. 06, 2024)

View and export this data going back to 2007. Start your Free Trial

What is Cyclopharm Price-to-Operating-Cash-Flow?

As of today (2024-06-06), Cyclopharm's share price is A$1.56. Cyclopharm's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was A$-0.08. Hence, Cyclopharm's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for Cyclopharm's Price-to-Operating-Cash-Flow or its related term are showing as below:

During the past 13 years, Cyclopharm's highest Price-to-Operating-Cash-Flow Ratio was 102.41. The lowest was 3.60. And the median was 13.23.

ASX:CYC's Price-to-Operating-Cash-Flow is not ranked ^*
in the Medical Devices & Instruments industry.
Industry Median: 20.43
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

Cyclopharm's Cash Flow from Operations per share for the six months ended in Dec. 2023 was A$-0.06. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was A$-0.08.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 12.60% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was -45.20% per year.

During the past 13 years, Cyclopharm's highest 3-Year average Operating Cash Flow per Share Growth Rate was 188.40% per year. The lowest was -208.10% per year. And the median was -18.10% per year.

Cyclopharm Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Cyclopharm's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cyclopharm Price-to-Operating-Cash-Flow Chart

Cyclopharm Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Price-to-Operating-Cash-Flow

Get a 7-Day Free Trial

Cyclopharm Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Price-to-Operating-Cash-Flow	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Cyclopharm's Price-to-Operating-Cash-Flow

For the Medical Devices subindustry, Cyclopharm's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cyclopharm's Price-to-Operating-Cash-Flow Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Cyclopharm's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Cyclopharm's Price-to-Operating-Cash-Flow falls into.

Cyclopharm Price-to-Operating-Cash-Flow Calculation

Cyclopharm's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	1.56	/	-0.077
	=

Cyclopharm's Share Price of today is A$1.56.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Cyclopharm's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was A$-0.08.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

Cyclopharm Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Cyclopharm's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Cyclopharm (ASX:CYC) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Cyclopharm Ltd (ASX:CYC) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

N/A

Address

Unit 4, 1 The Crescent, Kingsgrove, Sydney, NSW, AUS, 2208

Website

https://cyclopharm.com.au

Cyclopharm Ltd is a company that engages in the manufacture and sale of medical equipment and radiopharmaceuticals, including associated research and development. It operates through the following segments. The Technegas segment involves supplying diagnostic equipment and consumables used by physicians in the detection of pulmonary embolism, and a distributor of products to the diagnostic imaging sector. The Molecular Imaging segment offers to produce radiopharmaceuticals to be used by physicians in the detection of cancer, neurological disorders, and cardiac disease. The firm generates maximum revenue from the Technegas segment.

Cyclopharm (ASX:CYC) Headlines

No Headlines